human
infect
sever
acut
respiratori
syndrom
coronaviru
caus
coronaviru
diseas
current
cure
proteas
highli
conserv
proteas
indispens
replic
coronavirus
promis
target
develop
broadspectrum
antivir
drug
advanc
speed
drug
discoveri
develop
investig
inhibit
natur
product
deriv
chines
tradit
medicin
baicalin
baicalein
identifi
first
noncoval
nonpeptidomimet
inhibitor
exhibit
potent
antivir
activ
cellbas
system
remark
bind
mode
baicalein
determin
xray
protein
crystallographi
distinctli
differ
known
inhibitor
baicalein
perfectli
ensconc
core
substratebind
pocket
interact
two
catalyt
residu
crucial
subsit
oxyanion
loop
act
shield
front
catalyt
dyad
prevent
peptid
substrat
approach
activ
site
simpl
chemic
structur
uniqu
mode
action
potent
antivir
activ
vitro
coupl
favor
safeti
data
clinic
trial
emphas
baicalein
provid
great
opportun
develop
critic
need
anticoronavir
drug
authorfund
right
reserv
reus
allow
without
permiss
tradit
chines
medicin
tcm
evolv
thousand
year
invalu
sourc
drug
discoveri
develop
notabl
exampl
discoveri
artemisinin
qinghaosu
origin
isol
tcm
artemisia
annua
l
qinghao
mileston
treatment
malaria
tcm
well
purifi
natur
product
also
provid
rich
resourc
novel
antivir
drug
develop
sever
herbal
medicin
natur
product
shown
antivir
activ
viral
pathogen
among
root
scutellaria
baicalensi
georgi
huangqin
chines
frequent
use
tcm
prophylaxi
treatment
hepat
respiratori
disord
present
studi
enzymat
assay
perform
test
ingredi
isol
baicalensi
inhibitor
result
baicalin
baicalein
two
bioactiv
compon
baicalensi
identifi
novel
inhibitor
antivir
activ
infect
cell
crystal
structur
complex
baicalein
first
noncoval
nonpeptidomimet
smallmolecul
inhibitor
also
determin
reveal
uniqu
bind
mode
natur
product
proteas
pivot
role
proteas
process
polyprotein
individu
function
protein
viral
replic
highli
conserv
substrat
specif
enzym
among
variou
cov
make
promis
target
screen
inhibitor
fluoresc
reson
energi
transfer
fret
proteas
assay
appli
measur
proteolyt
activ
recombin
fluorogen
substrat
detail
assay
describ
experiment
section
fretbas
proteas
assay
util
screen
natur
product
novel
inhibitor
first
use
determin
inhibitori
activ
total
aqueou
extract
fraction
purifi
compound
baicalensi
see
supplementari
materi
fig
result
two
fraction
baicalensi
show
signific
inhibit
tabl
surprisingli
baicalin
major
compon
fraction
show
proteas
baicalein
major
compon
fraction
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
fig
tabl
accordingli
baicalin
baicalein
identifi
novel
nonpeptidomimet
inhibitor
singledigit
micromolar
potenc
valid
bind
baicalin
baicalein
exclud
suspicion
panassay
interfer
compound
pain
bind
affin
proteas
measur
isotherm
titrat
calorimetri
itc
wide
known
invalu
tool
use
determin
thermodynam
paramet
proteinligand
interact
kd
fig
b
tabl
result
kd
baicalin
baicalein
bind
respect
good
correl
mention
demonstr
specif
bind
compound
enzym
respons
bioactiv
moreov
itc
profil
combin
chemic
structur
suggest
baicalin
baicalein
act
noncoval
inhibitor
high
ligand
bind
effici
nativ
state
electrospray
ioniz
mass
spectrometri
esim
use
extens
directli
observ
nativ
state
protein
protein
complex
allow
direct
detect
proteinligand
noncoval
complex
kd
weak
mm
determin
protein
ligand
mz
unbound
protein
mz
abl
identifi
ligand
binder
correct
molecular
weight
ratio
intens
protein
ligand
peak
rel
unbound
protein
peak
provid
qualit
indic
ligandbind
affin
herein
esim
analysi
use
highresolut
magnet
reson
mass
spectrometri
mrm
carri
detect
bind
baicalin
baicalein
free
proteas
perform
optim
mass
rang
around
chang
state
isol
center
mass
quadrupol
mz
fig
ligandbind
screen
studi
two
charg
state
use
calcul
free
proteas
proteinligand
complex
intens
repres
spectra
sampl
contain
baicalin
baicalein
acquir
optim
screen
condit
shown
fig
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
demonstr
specif
bind
baicalin
baicalein
proteas
moreov
plot
fraction
bound
proteas
versu
total
concentr
baicalin
baicalein
obtain
kd
baicalin
baicalein
respect
fig
f
keep
result
itc
measur
mode
action
baicalein
structur
determin
associ
bind
explor
use
xray
protein
crystallographi
crystal
structur
complex
baicalein
determin
resolut
fig
tabl
proteas
catalyt
dyad
extend
bind
site
featur
share
sarscov
merscov
fig
inhibitor
bind
core
region
substratebind
site
surfac
proteas
domain
ii
fig
b
examin
activ
site
complex
reveal
three
phenol
hydroxyl
group
baicalein
made
multipl
hydrogen
bond
main
chain
well
side
chain
without
aid
buri
water
molecul
fig
carbonyl
group
establish
hydrogen
bond
main
chain
free
phenyl
ring
insert
subpocket
make
hydrophob
interact
multipl
residu
notabl
apart
hydrophob
interact
catalyt
also
form
distanc
sulfur
centroid
phenyl
ring
interact
aromat
ring
baicalein
respect
side
chain
also
establish
distanc
nitrogen
centroid
phenyl
ring
interact
baicalein
togeth
interact
contribut
lead
phenyl
ring
three
oh
group
sandwich
moreov
contact
middl
ring
baicalein
via
hydrophob
interact
consequ
baicalein
perfectli
ensconc
core
substratebind
pocket
interact
two
catalyt
residu
oxyanion
loop
residu
subsit
key
element
recognit
substrat
well
peptidomimet
inhibitor
although
baicalein
move
deepli
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
subpocket
phenol
hydroxyl
group
form
contact
crucial
residu
subpocket
via
water
molecul
aid
array
direct
indirect
hydrogen
bond
baicalein
fix
conform
flexibl
oxyanion
loop
serv
stabil
tetrahedr
transit
state
proteolyt
reaction
result
togeth
provid
molecular
detail
baicalein
recognit
explan
observ
potent
activ
small
molecul
proteas
amino
sequenc
display
sequenc
ident
sarscov
residu
differ
two
proteas
none
particip
direct
contact
baicalein
high
level
sequenc
identifi
two
proteas
allow
one
assum
baicalein
bind
sarscov
way
inhibit
assay
show
baicalein
also
inhibit
sarscov
thu
threedimension
model
sarscov
complex
baicalein
construct
superimpos
crystal
structur
sarscov
pdb
code
fig
bind
mode
baicalein
sarscov
distinct
differ
known
inhibitor
crystal
structur
inhibitorbound
sarscov
collect
comparison
analysi
fig
peptidomimet
inhibitor
delin
like
sword
compet
bind
substrat
baicalein
work
shield
front
two
catalyt
dyad
prevent
approach
substrat
activ
site
fig
uniqu
bind
mode
combin
high
ligandbind
effici
small
molecular
weight
render
baicalein
valuabl
drug
develop
evalu
antivir
efficaci
baicalin
baicalein
clinic
isol
vero
cell
cytotox
two
compound
cell
first
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
determin
assay
result
halfcytotox
concentr
two
compound
demonstr
low
cytotox
baicalin
baicalein
fig
subsequ
vero
cell
infect
sar
cov
cov
substrat
specif
featur
effici
cleavag
peptid
includ
leu
phe
met
val
ser
ala
gli
sequenc
cleavag
site
indic
crystal
structur
reveal
remark
degre
conserv
substratebind
site
particularli
crucial
subsit
accordingli
substrat
analog
mimet
attach
chemic
warhead
target
catalyt
cystein
design
peptidomimet
inhibitor
coval
mechan
action
seri
diamid
acetamid
act
noncoval
sarscov
inhibitor
bind
mode
examin
crystal
structur
report
less
peptidomimet
inhibitor
continu
develop
compound
absent
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
although
sever
small
molecul
declar
inhibitor
solid
valid
bind
itc
complex
structur
determin
lack
none
known
inhibitor
move
clinic
trial
consider
effort
discov
novel
small
molecul
inhibitor
urgent
need
view
long
histori
tcm
treat
viral
infect
urgent
need
drug
develop
investig
potenti
natur
product
isol
baicalensi
longterm
use
tcm
baicalensi
also
major
compon
chines
tradit
patent
medicin
shuanghuanglian
qingfei
paidutang
proven
effect
cure
patient
china
result
identifi
two
small
natur
product
baicalin
baicalein
first
class
noncoval
nonpeptidomimet
inhibitor
enzymat
assay
combin
itc
esim
xray
protein
crystallographi
studi
contrast
avail
coval
peptidomimet
inhibitor
proteas
itc
measur
also
reveal
two
compound
noncoval
inhibitor
high
ligandbind
effici
bind
mode
baicalein
proteas
reveal
crystal
structur
demonstr
uniqu
proteinligand
interact
pattern
util
baicalein
block
proteolyt
activ
crystal
structur
baicaleinbound
thu
report
first
demonstr
best
knowledg
author
declar
compet
interest
complex
structur
deposit
protein
data
bank
access
code
data
avail
correspond
author
upon
reason
request
tabl
refer
refer
note
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
chemic
shift
report
ppm
coupl
constant
j
hertz
chemic
shift
report
ppm
unit
refer
standard
cdna
full
length
sarscov
clone
vector
obtain
sarscov
authent
n
c
termin
four
amino
acid
avlq
insert
gst
tag
full
length
sarscov
eight
amino
acid
gphhhhhh
ad
ctermin
plasmid
transform
cell
protein
express
n
termin
gst
tag
four
amino
acid
avlq
selfcleav
express
protein
authent
n
termin
purifi
ninta
column
ge
healthcar
transform
cleavag
buffer
mm
nacl
mm
tri
ph
contain
human
rhinoviru
proteas
remov
addit
residu
result
protein
sampl
pass
size
exclus
chromatographi
ge
healthcar
elut
protein
sampl
store
solut
mm
tri
ph
enzymat
inhibit
assay
nativ
state
mass
spectrometri
studi
protein
crystal
obtain
gst
tag
cdna
full
length
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
insert
presciss
proteas
digest
site
vector
plasmid
transform
cell
protein
express
express
protein
purifi
gst
column
ge
healthcar
follow
size
exclus
chromatographi
ge
healthcar
result
protein
store
solut
mm
tri
ph
isotherm
titrat
calorimetri
measur
fluoresc
reson
energi
transfer
fret
proteas
assay
appli
measur
inhibitori
activ
compound
sarscov
baicalensi
decoct
piec
g
boil
ml
water
hour
twice
filtrat
combin
aqueou
extract
evapor
reduc
pressur
residu
dri
lyophil
mg
dri
extract
subject
water
autopurif
hplc
elut
mecn
water
contain
hcooh
eluent
fraction
collect
automat
fraction
collector
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
combin
peak
uv
nm
elsd
detector
total
fraction
obtain
recoveri
rate
assay
inhibit
ligand
bind
screen
dissoci
constant
kd
determin
magnitud
size
set
k
singl
scan
ad
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
protein
sampl
buffer
exchang
mm
ammonium
acet
buffer
ph
optim
ms
condit
protein
dilut
ligand
bind
screen
studi
kd
determin
sampl
prepar
protein
ligand
seri
concentr
baicalin
baicalein
incub
time
h
three
independ
experi
perform
determin
kd
mass
spectra
deconvolut
dataanalysi
bruker
dalton
bremen
germani
charg
state
use
calcul
free
protein
proteinligand
complex
intens
rel
abund
proteinligand
complex
total
protein
mass
spectra
calcul
report
previous
purifi
protein
concentr
mgml
crystal
one
hour
incub
protein
mm
baicalein
carri
crystal
condit
screen
crystal
complex
obtain
mix
equal
volum
proteinbaicalein
reservoir
mm
me
ph
dmso
handingdrop
vapor
diffus
method
crystal
flash
frozen
liquid
nitrogen
presenc
reservoir
solut
supplement
glycerol
xray
diffract
data
collect
beamlin
shanghai
synchrotron
radiat
facil
data
process
softwar
packag
complex
structur
solv
molecular
replac
use
program
phaser
search
model
pdb
code
model
built
use
coot
refin
simulatedann
protocol
implement
program
phenix
refin
structur
deposit
protein
data
bank
access
code
list
tabl
complet
statist
well
qualiti
solv
structur
also
shown
tabl
vero
cell
line
obtain
american
type
cultur
collect
atcc
manassa
usa
maintain
minimum
eagl
medium
mem
gibco
invitrogen
supplement
fetal
bovin
serum
fb
invitrogen
uk
humid
incub
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
fig
chemic
structur
baicalin
baicalein
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
baicalein
shown
green
sphere
inhibitor
togeth
two
catalyt
residu
shown
stick
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
outlier
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
